AMPK: Potential Therapeutic Target for Ischemic Stroke

Overview

Journal Theranostics

Date 2018 Sep 15

PMID 30214637

Citations 91

Authors

Shuai Jiang

Tian Li

Ting Ji

Wei Yi

Zhi Yang

Simeng Wang

Yang Yang

Chunhu Gu

Affiliations

Soon will be listed here.

Abstract

5'-AMP-activated protein kinase (AMPK), a member of the serine/threonine (Ser/Thr) kinase group, is universally distributed in various cells and organs. It is a significant endogenous defensive molecule that responds to harmful stimuli, such as cerebral ischemia, cerebral hemorrhage, and, neurodegenerative diseases (NDD). Cerebral ischemia, which results from insufficient blood flow or the blockage of blood vessels, is a major cause of ischemic stroke. Ischemic stroke has received increased attention due to its '3H' effects, namely high mortality, high morbidity, and high disability. Numerous studies have revealed that activation of AMPK plays a protective role in the brain, whereas its action in ischemic stroke remains elusive and poorly understood. Based on existing evidence, we introduce the basic structure, upstream regulators, and biological roles of AMPK. Second, we analyze the relationship between AMPK and the neurovascular unit (NVU). Third, the actions of AMPK in different phases of ischemia and current therapeutic methods are discussed. Finally, we evaluate existing controversy and provide a detailed analysis, followed by ethical issues, potential directions, and further prospects of AMPK. The information complied here may aid in clinical and basic research of AMPK, which may be a potent drug candidate for ischemic stroke treatment in the future.

Citing Articles

Effect of metformin on the clinical outcomes of stroke in patients with diabetes: a systematic review and meta-analysis.

Liu J, Huang Z, Luo F, Guo Y, Li Y, Wen J BMJ Open. 2025; 15(1):e092214.

PMID: 39819905 PMC: 11751969. DOI: 10.1136/bmjopen-2024-092214.

Z-Ligustilide: A Potential Therapeutic Agent for Atherosclerosis Complicating Cerebrovascular Disease.

Shen L, Tian Q, Ran Q, Gan Q, Hu Y, Du D Biomolecules. 2025; 14(12.

PMID: 39766330 PMC: 11726876. DOI: 10.3390/biom14121623.

The Role and Mechanism of Metformin in the Treatment of Nervous System Diseases.

Li H, Liu R, Liu J, Qu Y Biomolecules. 2025; 14(12.

PMID: 39766286 PMC: 11673726. DOI: 10.3390/biom14121579.

Protopine Exerts Neuroprotective Effects on Neonatal Hypoxic-Ischemic Brain Damage in Rats via Activation of the AMPK/PGC1α Pathway.

Lu L, Pang M, Chen T, Hu Y, Chen L, Tao X Drug Des Devel Ther. 2024; 18:4975-4992.

PMID: 39525050 PMC: 11549892. DOI: 10.2147/DDDT.S484969.

A novel ferroptosis inhibitor, Thonningianin A, improves Alzheimer's disease by activating GPX4.

Yong Y, Yan L, Wei J, Feng C, Yu L, Wu J Theranostics. 2024; 14(16):6161-6184.

PMID: 39431016 PMC: 11488096. DOI: 10.7150/thno.98172.

References

Ohira M, Endo K, Saiki A, Miyashita Y, Terai K, Murano T . Atorvastatin and pitavastatin enhance lipoprotein lipase production in L6 skeletal muscle cells through activation of adenosine monophosphate-activated protein kinase. Metabolism. 2012; 61(10):1452-60. DOI: 10.1016/j.metabol.2012.03.010. View

Gammie S, Driessen T, Zhao C, Saul M, Eisinger B . Genetic and neuroendocrine regulation of the postpartum brain. Front Neuroendocrinol. 2016; 42:1-17. PMC: 5030130. DOI: 10.1016/j.yfrne.2016.05.002. View

Ran Q, Chen H, Liu Y, Yu H, Shi F, Wang M . Electroacupuncture preconditioning attenuates ischemic brain injury by activation of the adenosine monophosphate-activated protein kinase signaling pathway. Neural Regen Res. 2015; 10(7):1069-75. PMC: 4541236. DOI: 10.4103/1673-5374.160095. View

Carling D . AMPK signalling in health and disease. Curr Opin Cell Biol. 2017; 45:31-37. DOI: 10.1016/j.ceb.2017.01.005. View

van der Worp H, Sena E, Donnan G, Howells D, Macleod M . Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis. Brain. 2007; 130(Pt 12):3063-74. DOI: 10.1093/brain/awm083. View

Calabrese M, Rajamohan F, Harris M, Caspers N, Magyar R, Withka J . Structural basis for AMPK activation: natural and synthetic ligands regulate kinase activity from opposite poles by different molecular mechanisms. Structure. 2014; 22(8):1161-1172. DOI: 10.1016/j.str.2014.06.009. View

Chakkarapani E, Dingley J, Liu X, Hoque N, Aquilina K, Porter H . Xenon enhances hypothermic neuroprotection in asphyxiated newborn pigs. Ann Neurol. 2010; 68(3):330-41. DOI: 10.1002/ana.22016. View

Kone M, Pullen T, Sun G, Ibberson M, Martinez-Sanchez A, Sayers S . LKB1 and AMPK differentially regulate pancreatic β-cell identity. FASEB J. 2014; 28(11):4972-85. PMC: 4377859. DOI: 10.1096/fj.14-257667. View

Li T, Jiang S, Han M, Yang Z, Lv J, Deng C . Exogenous melatonin as a treatment for secondary sleep disorders: A systematic review and meta-analysis. Front Neuroendocrinol. 2018; 52:22-28. DOI: 10.1016/j.yfrne.2018.06.004. View

10.

Leuner B, Sabihi S . The birth of new neurons in the maternal brain: Hormonal regulation and functional implications. Front Neuroendocrinol. 2016; 41:99-113. PMC: 4942360. DOI: 10.1016/j.yfrne.2016.02.004. View

11.

Zeng J, Liu W, Fan Y, He D, Li L . PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy. Theranostics. 2018; 8(1):109-123. PMC: 5743463. DOI: 10.7150/thno.20356. View

12.

Hyttinen J, Blasiak J, Niittykoski M, Kinnunen K, Kauppinen A, Salminen A . DNA damage response and autophagy in the degeneration of retinal pigment epithelial cells-Implications for age-related macular degeneration (AMD). Ageing Res Rev. 2017; 36:64-77. DOI: 10.1016/j.arr.2017.03.006. View

13.

Dumais K, Veenema A . Vasopressin and oxytocin receptor systems in the brain: Sex differences and sex-specific regulation of social behavior. Front Neuroendocrinol. 2015; 40:1-23. PMC: 4633405. DOI: 10.1016/j.yfrne.2015.04.003. View

14.

Wan D, Zhou Y, Wang K, Hou Y, Hou R, Ye X . Resveratrol provides neuroprotection by inhibiting phosphodiesterases and regulating the cAMP/AMPK/SIRT1 pathway after stroke in rats. Brain Res Bull. 2016; 121:255-62. DOI: 10.1016/j.brainresbull.2016.02.011. View

15.

Ashabi G, Khalaj L, Khodagholi F, Goudarzvand M, Sarkaki A . Pre-treatment with metformin activates Nrf2 antioxidant pathways and inhibits inflammatory responses through induction of AMPK after transient global cerebral ischemia. Metab Brain Dis. 2014; 30(3):747-54. DOI: 10.1007/s11011-014-9632-2. View

16.

Lewinska A, Adamczyk-Grochala J, Deregowska A, Wnuk M . Sulforaphane-Induced Cell Cycle Arrest and Senescence are accompanied by DNA Hypomethylation and Changes in microRNA Profile in Breast Cancer Cells. Theranostics. 2017; 7(14):3461-3477. PMC: 5596436. DOI: 10.7150/thno.20657. View

17.

Xiong X, Liu L, Yang Q . Functions and mechanisms of microglia/macrophages in neuroinflammation and neurogenesis after stroke. Prog Neurobiol. 2016; 142:23-44. DOI: 10.1016/j.pneurobio.2016.05.001. View

18.

Gowans G, Hawley S, Ross F, Grahame Hardie D . AMP is a true physiological regulator of AMP-activated protein kinase by both allosteric activation and enhancing net phosphorylation. Cell Metab. 2013; 18(4):556-66. PMC: 3791399. DOI: 10.1016/j.cmet.2013.08.019. View

19.

Wang P, Xu T, Guan Y, Tian W, Viollet B, Rui Y . Nicotinamide phosphoribosyltransferase protects against ischemic stroke through SIRT1-dependent adenosine monophosphate-activated kinase pathway. Ann Neurol. 2011; 69(2):360-74. DOI: 10.1002/ana.22236. View

20.

Sheng R, Zhang L, Han R, Liu X, Gao B, Qin Z . Autophagy activation is associated with neuroprotection in a rat model of focal cerebral ischemic preconditioning. Autophagy. 2010; 6(4):482-94. DOI: 10.4161/auto.6.4.11737. View